Cleared Traditional

K885295 - IMX RUBELLA IGM, MICROPART. ENZYME IMMUNOASSAY (FDA 510(k) Clearance)

Jun 1989
Decision
178d
Days
Class 2
Risk

K885295 is an FDA 510(k) clearance for the IMX RUBELLA IGM, MICROPART. ENZYME IMMUNOASSAY. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Rubella (Class II - Special Controls, product code LFX).

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on June 23, 1989, 178 days after receiving the submission on December 27, 1988.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3510.

Submission Details

510(k) Number K885295 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 1988
Decision Date June 23, 1989
Days to Decision 178 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code LFX — Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3510